Δ4-p63 Enhances Epithelial Stem Cell Clonogenicity and Cooperates with Oncogenic KRAS to Promote Squamous Dysplasia

The skin is more than a simple covering; it is a living, breathing barrier that constantly renews itself. To maintain this protection, the body relies on a small population of specialized cells called stem cells. These are the master builders of the tissue, capable of dividing to create new cells while also preserving their own numbers for future repairs. In healthy skin, these stem cells are kept in a careful balance: they grow enough to replace worn-out tissue but stop before they take over. When this balance breaks, the result can be uncontrolled growth, which is the starting point for many types of cancer. One of the most important regulators of this balance is a protein called p63. This molecule acts like a switchboard operator, turning on the genes that tell skin cells to stay strong, divide when needed, and maintain their identity. Without p63, the skin cannot form properly, and the stem cells lose their ability to multiply.

Scientists have long known that p63 comes in different versions, or isoforms, which are like slightly different models of the same tool. Some versions are essential for building the skin, while others help maintain it. However, researchers recently noticed something unusual in human skin cancers. In these tumors, a specific, rare version of p63 appears that is not found in normal skin. This version is missing a small piece of its structure, a section known as exon 4. The big question was whether this missing piece simply broke the protein, making it weaker, or if it changed the protein's behavior in a new and dangerous way. If it were just a broken tool, the cancer might be explained by a loss of function. But if the missing piece created a new kind of tool, it could be actively reshaping how skin cells behave, potentially setting the stage for disease even before a tumor appears.

A team of researchers set out to answer this by creating a special line of mice designed to carry this specific change. They engineered the mice so that one copy of their p63 gene was missing exon 4, mimicking the condition seen in human cancer cells. The first thing they observed was surprising: these mice looked completely normal. Their skin was healthy, they grew to adulthood, and they did not develop spontaneous tumors on their own. To the naked eye, and even under a microscope looking at their skin tissue, there was no sign of trouble. This suggested that having this altered protein was not enough to cause cancer by itself. The body's natural checks and balances seemed to be holding the line, keeping the cells in check despite the presence of the unusual protein.

However, the story changed when the researchers looked closer at the cells themselves, away from the protective environment of the body. They took skin cells from these mice and grew them in a dish, a setting where the cells are free from the usual signals that keep them in line. In this environment, the difference became stark. Cells from the mice with the altered p63 gene grew into much larger, more robust colonies than cells from normal mice. They multiplied with greater speed and persistence, showing a hidden potential for expansion that was masked in the living animal. This finding revealed that the altered protein was not broken; rather, it had changed the nature of the stem cells, giving them an intrinsic ability to grow more aggressively when the usual constraints were removed.

To understand why this happened, the scientists examined how the protein interacted with the cell's genetic material. They found that the altered protein still bound to the DNA in almost the same places as the normal version. It did not lose its ability to find its targets. But when they looked more closely, they saw that the altered protein had a new preference. While the normal protein focused on a specific set of genes related to standard skin maintenance, the altered version spent more time near a different group of genes, including those involved in responding to stress and growth signals. This shift in focus suggested that the protein was not just doing less work; it was doing different work, subtly rewiring the cell's internal instructions to favor a state of high readiness for growth.

The researchers then tested what would happen if this altered state met a known driver of cancer. They introduced a powerful cancer-causing mutation, known as KRAS, into the mice with the altered p63 gene. In normal mice with this mutation, the skin developed severe abnormalities and pre-cancerous growths. But in the mice with the altered p63, the reaction was far more extreme. The skin grew thick, disordered, and rapidly, showing signs of severe dysplasia much more quickly and intensely than in the other groups. This proved that the altered p63 protein and the cancer-causing mutation worked together. The altered protein had prepared the stem cells to be more receptive to the cancer signal, creating a fertile ground where the mutation could cause much more damage than it would have on its own.

The study concludes that the appearance of this specific p63 variant is not a passive sign of a dying cell or a simple loss of function. Instead, it represents a fundamental shift in the identity of the skin stem cell. By changing which genes the protein prioritizes, the cell enters a state that is perfectly fine for normal life but becomes dangerously vulnerable when faced with other threats. It is as if the cell has been tuned to a higher frequency of growth; in a quiet room, it sounds normal, but when a loud noise comes, it amplifies the sound into a roar. This discovery suggests that the path to skin cancer may begin not with a single catastrophic error, but with a subtle change in the cell's internal programming that makes it more likely to fall into chaos when the right conditions arise.